A

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Senior Technician Analytics

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeHeidelberg, Germany

About the Job

Requirements

  • An above-average vocational qualification as a chemical laboratory technician or chemical-technical assistant, or alternatively a very good bachelor's degree in Chemistry or a comparable field.
  • At least five years of professional experience in a pharmaceutical-industrial environment is essential.
  • Demonstrated practical experience with analytical methods and instrumental analytics, particularly HPLC and HPLC-MS, is required.
  • Knowledge of other techniques such as particle and aggregate analytics is advantageous.
  • Basic knowledge of relevant guidelines is desirable.
  • A conscientious and careful working style is required.
  • Good spoken and written English is required.

Responsibilities

  • Conduct pharmaceutical-chemical investigations and stability studies, from starting materials through product control.
  • Apply various analytical methods, including chromatography, spectroscopy, and wet chemistry.
  • Develop and pre-validate assays and support formulation development.
  • Maintain and oversee laboratory equipment.
  • Write and carry out work instructions.
  • Document results and prepare protocols and reports.

Desired Qualifications

  • Knowledge of other techniques such as particle and aggregate analytics.
  • Basic knowledge of relevant guidelines.

About the Company

Ascendis Pharma

Biopharmaceutical company developing long-acting prodrugs

Ascendis Pharma uses its TransCon technology to create long-acting prodrugs for rare endocrine diseases, with expansions into oncology and ophthalmology. The platform temporarily attaches an unmodified drug to an inert carrier and releases the active drug in a predictable, sustained way after injection, reducing how often patients must dosing. It differentiates itself through a proprietary delivery system and a track record that includes marketed therapies like SKYTROFA for pediatric growth hormone deficiency and YORVIPATH for hypoparathyroidism, along with collaborations such as a Novo Nordisk deal. The company aims to improve patient outcomes by enabling easier, less frequent dosing while expanding its pipeline across rare endocrine diseases, cancer, and eye diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
2007

Recently Posted Jobs

Explore more opportunities at Ascendis Pharma

See more jobs